Longitudinal Assessment of Urinary PCA3 for Predicting Prostate Cancer Grade Reclassification in Favorable Risk Men during Active Surveillance

BACKGROUND: To assess the utility of urinary prostate cancer antigen 3 (PCA3) as both a one-time and longitudinal measure in men on active surveillance (AS). METHODS: The Johns Hopkins AS program monitors men with favorable-risk prostate cancer with serial PSA, digital rectal examination (DRE), pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosoian, Jeffrey J., Patel, Hiten D., Mamawala, Mufaddal, Landis, Patricia, Wolf, Sacha, Elliott, Debra J., Epstein, Jonathan I., Carter, H. Ballentine, Ross, Ashley E., Sokoll, Lori J., Pavlovich, Christian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555773/
https://www.ncbi.nlm.nih.gov/pubmed/28417979
http://dx.doi.org/10.1038/pcan.2017.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555773/
https://www.ncbi.nlm.nih.gov/pubmed/28417979
http://dx.doi.org/10.1038/pcan.2017.16

Ejemplares similares